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Abstract 
 
Primary tumors of the heart are rare. However, among them cardiac myxoma is the most common tumor accounting 
for half of the primary cardiac neoplasms. 
 
 About 75% of cardiac myxomas are located in the left atrium, and 25% 
are located in the right atrium. These are thought to be arising from remnants of subendocardial vasoformative 
reserve cells or multipotential primitive mesenchymal cells in the fossa ovalis and surrounding endocardium, which 
can differentiate along a variety of cell lineages including epithelial, hematopoietic, and muscle cells. Although some 
cases are discovered incidentally by echocardiographic examination, it was recognized in most of the patients by 
various symptoms caused by the release of inflammatory cytokines such as interleukin-6 (IL-6), obstruction of 
intracardiac blood flow, or embolization. Cardiac myxoma has many undetermined interesting issues regarding its 
origin, nature as a tumor, varying clinical manifestations, and the presence of both sporadic and familial types. 
Recent evidence revealed that cardiac myxomas are benign neoplasms and slowly proliferating lesions. The 
existence of its malignant counterpart is controversial. However, recurrence after surgical excision or metastasis has 
been  reported.  We hereby present a case report of a young gentleman who presented with history of sudden onset of 
weakness and cerebellar signs. Urgent CT scan revealed hypodensities of bilateral occipital lobes and cerebellum 
suggestive of infarcts. Urgent echocardiography denoted large left atrial myxoma. The tumor was excised and the 
patient recovered well. 
Keywords: Atrial myxoma, stroke, cerebellar signs, embolic phenomena 
 
 
Correspondence: 
Dr. Azhar bin Amir Hamzah, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 
16150 Kubang Kerian, Kelantan, Malaysia. Tel: +609-767 6774, Email: drazhar786@hotmail.com
  
Date of submission: 25th June 2011                Date of acceptance: 19th Sept 2011            Date of publication: 3rd
 
 Oct 2011 
 
  
Introduction 
 
Atrial myxoma is not an uncommon condition among 
patients. However, it is very uncommon for a patient 
with cardiac myxoma presenting with extra-cardiac 
symptoms and signs  such as cerebellar manifestation.  
The commonest presenting feature of left atrial (LA) 
myxomas are mitral obstructive symptoms. 
Morphologically, LA myxoma are classified into  two 
distinct types:- the  round type characterized by round 
shape with non mobile surface and polypoid type, 
characterized by irregular shape with mobile surface. 
Studies suggest a higher incidence of embolic 
episodes in patients with friable polypoid type of 
tumor (1). We present an unique case of a young man 
who had a very LA myxoma without mitral 
obstructive symptoms, but presented with cerebellar 
manifestation.  
 
 Though, classically the polypoidal 
type of atrial myxoma tends to more prone for 
embolic phenomena, our case was an exception to this 
trend:  resulting in multiple emboli despite belonging 
to the round type.    
Case Report  
 
NAAZ, a 25-year-old Malay  gentleman, who was 
previously well and apparently was about to get 
married the following week, presented to the 
Case report 
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Emergency Department, HUSM,  with  history of 
sudden onset of weakness of both lower limbs and 
abnormal movement of upper limb one day prior to 
admission. He had no history of seizures, fall, trauma, 
fever of any symptoms suggestive of increased of 
intracranial pressure. The weakness was progressively 
worsening the next day, associated with slurred 
speech. There was no history of dysphagia, nasal 
regurgitation, diplopia, bowel or bladder 
incontinence. He was not a diagnosed case of diabetes 
mellitus, hypertension, coronary artery disease or 
rheumatic heart disease. In fact, there is no similar 
illness in the family. 
 
Upon admission, he was alert and conscious. His 
speech was slurred with dysarthria. The pulse was 
76/min regular rhythm, normal character and good 
volume and the blood pressure was 130/75 mmHg. 
Cardiorespiratory examination revealed normal 
findings and per abdominal examination was normal. 
On neurological examination, this patient had 
bilateral intentional tremor, dysdiadochokinesis, 
positive past pointing test and heel to shin test. 
Cranial nerves were normal. Deep reflexes were brisk 
in all four limbs with extensor plantars bilaterally. No 
papilloedema was observed. 
 
Urgent Computerised tomographic scan showed 
hypodensities of bilateral occipital lobes and 
cerebellum suggestive of infarcts. The ventricular 
system was normal and there was no midline shift. 
Echocardiography revealed a large (68 x 42 mm) 
homogeneous tumor attached to the interatrial septum, 
which was prolapsing into left ventricle during diastole.  
Mild mitral regurgitation was noted. The diastolic 
gradient across the mitral valve was insignificant. A 
diagnosis of LA myxoma with multiple brain emboli 
was made. There was no progressive deterioration of 
neurological status. This patient was referred to 
Cardiothoracic Unit for further management.  
 
He was planned for excisional biopsy. 
Intraoperatively, we noted a round shaped with non 
mobile surface LA myxoma tumor attached to the 
interatrial septum, measuring 75x 45x68 mm. 
Intraoperative and postoperative outcome was 
uneventful. Patient recovered well with no residual 
neurological/ cerebellar symptom. Histopathological 
examination results confirmed atrial myxoma. Patient 
was seen twice during the follow up and he was very 
well with no evidence of recurrence. 
 
Discussion 
 
Atrial myxomas represent approximately 50% of all 
cardiac tumors, occurring mainly in the 3rd–6th decade 
of life (1). The annual incidence is 0.5 per million 
populations, (2) with 75% of cases occurring in the left 
atrium. There is a 2:1 
 
female preponderance (3). 
They originate from subendocardial mesenchymal 
cells mainly from the left atrium. Although atrial 
myxoma is mostly sporadic, at least 7% of cases are 
familial (4).  The best described familial type is 
Carney complex, characterized by cutaneous spotty 
pigmentation, cutaneous and cardiac myxomas, 
nonmyxomatous extracardiac tumours and 
endocrinopathies. It is transmitted in an autosomal 
dominant manner, through a causative mutation of the 
PRKAR1  gene located on the long arm of 
chromosome 17 (17q22-24 region) (5). 
 
   
Patients with LA myxoma usually present with signs 
of cardiac failure due to obstructed ventricular filling 
causing dyspnoea, pulmonary edema, and right heart 
failure. In some cases, it leads to syncope, sudden 
death, or signs of systemic embolism.
 
  
According to researchers, symptoms associated with 
embolic phenomena such as stroke or transient 
ishchemic attack is more common in young adults (1 
in 250) than in older patients with these problems (1 
in 750) (1). This patient conforms to most of the 
epidemiological studies as this young patient (in his 
3rd
 
 decade) presented with neurological deficit due to 
embolic phenomena of atrial myxoma. 
The presentation of atrial myxoma often comprises a 
diagnostic triad (summarized in Table 1). The 
embolization of tumor particles or thrombotic 
material covered with tumor cells occurs in 10–45% 
of myxoma patients. In at least half of the cases 
cerebral arteries are affected, leading to embolic 
ischemic stroke (6). In contrast, the formation of 
intracranial aneurysms associated with left atrial 
myxomas is a less common phenomenon. Other rare 
neurologic complications include parenchymal brain 
metastases and intracerebral hemorrhage 
 
due to 
ruptured aneurysms (7, 8). 
Atrial myxomas have been estimated to cause up to 
0.5% of ischemic strokes (9). In a recently published 
series, the median delay between onset of symptoms and 
diagnosis in myxoma patients with neurologic 
manifestation-mainly transient ischemic attacks-was 36 
months (10). Cerebral imaging often demonstrates 
multiple infarcts suggestive of an embolic cause, but in 
some cases it may show only small subcortical ischemic 
lesions mimicking lacunar disease (11). Transthoracic 
echocardiography has a sensitivity of around 90% in 
detection of left atrial myxoma; the sensitivity of 
transesophageal examination is even higher (12). 
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Table 1: Diagnostic triad in presentation of atrial myxoma 
 
Features Manifestation Frequency (% of patients) 
Obstructive 
symptoms 
Heart failure, syncope, sudden death (rare) 6,7 54-95 
Constitutional 
symptoms 3, 6
May mimic autoimmune disease or vasculitis; myalgia, arthralgia, weight 
loss, fatigue, fever, Raynaud’s phenomenon. Finger clubbing . 
34-90 
Embolic 
phenomena 
Emboli may travel to any organ, but 73% reach central nervous system, 
including spinal cord 6-8 
10-45 
 
Active illness is often accompanied by elevation of 
ESR and C-reactive protein, hyperglobulinemia and 
anemia. Constitutional symptoms may be mediated by 
interleukin-6, produced 
 
by the myxoma itself (13). 
Morphologically, two distinct types of LA myxomas 
have been described; round type characterized by 
round shape with nonmobile surface and polypoid 
type, characterized by irregular shape with mobile 
surface (14). Studies by Moriyama et al (15) suggest a 
higher incidence of embolic episodes in patients with 
friable polypoid type of tumor.  
 
Although cardiac myxomas usually present as a 
benign neoplasm, there are many reports suggesting 
its malignancy, including recurrence of the tumor, 
locally invasive myxoma, extension from the heart, 
and distant metastasis or peripheral tumor mass (16-
18). 
 
 Cardiac myxomas are generally thought curable 
by surgical resection of the primary tumor, but 
recurrence can occur at the site of the original tumor, 
at multiple intracardiac lesions, and at sites outside 
the heart.  
Recurrence of cardiac myxoma has been observed in 
about 3% of patients in sporadic cases, and 20% in 
Carney complex. Cardiac recurrence may be 
secondary to incomplete resection of the tumor, 
implantation from the original tumor, unrecognized 
multicentric origin, or the new growth of pretumor or 
reserve cells (16). 
 
 These recurrences may grow faster 
and be more infiltrative than the original tumor.  
Gerbode et al. first reported recurrence of left atrial 
myxoma four years after initial excision (17).  They 
postulated incomplete removal at the first operation 
and recommended wide resection of the interatrial 
septum around the base or stalk of the tumor. In 
English literature, Shinfeld et al. collected 584 
patients with cardiac myxomas and found 42 patients 
with first recurrence, and they found very few cases 
(1.3%) of repeated recurrence (18).  
 
They reported the 
age range at the time of first surgical resection was 7 
to 62 years (mean, 32.7 years), and reoperation was 
performed at between 3 months and 14 years later 
(average, 3.9 years). Of the 42 cases of recurrence 
after left atrial myxoma, the second tumor appeared in 
the left atrium in 83%, in the right atrium in 14%, and 
at other sites in the heart in 7%. The tumor recurred 
at, or close to, the original site of the left atrium in 
85% of cases.  
Tumor emboli may go to any vascular bed and tumor 
cells may remain viable at the site of embolization, 
thus forming distant metastasis or peripheral tumor 
mass. As a benign tumor character of cardiac 
myxoma and tumor location of it in the cardiac 
chamber, its metastasis is usually intravascular and 
present delayed occurrence after resection of the 
cardiac lesion. Few researchers pointed out that 
malignancy of atrial myxomas is predicated on 
biologic behavior rather than on histologic appearance 
(19). 
 
Researchers described a case of metastatic myxoma to 
soft tissue and bone (20).  Cerebral metastasis from 
myxoma has also been reported (20). Wada et al. 
reported a case of a 70- year-old man who had an 
atrial myxoma and two metastatic myxomas in the 
brain (21).
 
  
The intracranial lesions were in fact diagnosed before 
the cardiac myxoma, since the patient developed 
hemiparesis before his cardiac symptoms occurred. 
Histopathological examination showed all lesions to 
be benign myxomas. Interestingly, high 
concentrations of IL-6 were present in the patient’s 
serum and cardiac myxoma. Thus, they suggested that 
IL-6 may possibly potentiate metastasis of cardiac 
myxoma. Failure of constitutional symptoms to 
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resolve and of elevated gamma globulins and 
sedimentation rates to return to normal after 
technically successful resection of a primary cardiac 
tumor may suggest residual extracardiac tumor and 
may serve as a means of identifying the malignant 
cardiac myxoma. The potential for malignant change 
in cardiac myxoma is controversial. Shinfeld et al. 
reported same-site recurrence with more aggressive 
histology, then second recurrence with multiple 
smaller myxomas elsewhere in the left atrium (18). 
Although the first lesion was typically benign, the 
second recurrence was clearly malignant, and the 
patient died with extensive left atrial sarcoma. 
Sequential malignant transformation of cardiac 
myxoma is very rare. 
 
Appraisal of this case 
 
Several unique clinical features prompted us to report 
this case. First, though atrial myxoma  presenting with 
embolic phenomena cause stroke due cerebral 
ischemia is quite common , but it is uncommon for  
cerebellar involvement whereby patient presenting 
with cerebellar signs,  hitherto unreported, to our 
knowledge (2,3,4,5,6,7,8,9,10) . 
 
Second, the commonest presenting feature of LA 
myxomas are mitral obstructive symptoms which 
were absent in our case, despite the large size of the 
tumor. Neither did he have any constitutional 
symptoms (1, 6,7,8,9,12,13,14,15). 
 
Thirdly the morphology and the presentation of the 
patient is interesting. As suggested by Ha JW et al 
(14), morphologically, LA myxoma are classified into  
two distinct types: the  round type characterized by 
round shape with nonmobile surface and polypoid 
type, characterized by irregular shape with mobile 
surface. Studies suggest a higher incidence of embolic 
episodes in patients with friable polypoid type of 
tumor (15). Our case was an exception to this trend 
resulting in multiple emboli despite belonging to the 
round type. In fact, the tumours of round type are also 
less likely to prolapse into LV, unlike this patient. 
 
Conclusion 
 
Atrial myxoma is a benign cardiac tumour which 
could manifest in a various forms of clinical 
presentation. The spectrum of this disease can remain 
asymptomatic for many years or it can even present 
with embolic phenomena with severe neurological 
deficit and even death. 
 
 
 
This is a unique case because: 
 
1. Though atrial myxoma can present with 
embolic phenomena cause stroke due 
cerebral ischemia, but it is uncommon for 
cerebellar involvement. 
2. The commonest presenting feature of LA 
myxomas are mitral obstructive symptoms 
which were absent in our case, despite the 
large size of the tumor. Neither did this 
patient have any constitutional symptoms.  
 
The morphology and the presentation of the patient is 
interesting. Though studies suggest a higher incidence 
of embolic episodes in patients with friable polypoid 
type of tumor, our case was an exception to this trend 
resulting in multiple emboli despite belonging to the 
round type. In fact, the tumours of round type are also 
less likely to prolapse into LV, unlike this patient. 
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